loadpatents
name:-0.020596981048584
name:-0.012850046157837
name:-0.0015850067138672
Miller; Warren Kenyon Patent Filings

Miller; Warren Kenyon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Miller; Warren Kenyon.The latest application filed is for "colloidal dispersion comprising hpmcas".

Company Profile
1.19.16
  • Miller; Warren Kenyon - Bend OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Colloidal dispersion comprising HPMCAS
Grant 10,471,152 - Cape , et al. Nov
2019-11-12
Colloidal Dispersion Comprising Hpmcas
App 20170281780 - Cape; Jonathan Leonard ;   et al.
2017-10-05
Pharmaceutical compositions comprising nanoparticles and a resuspending material
Grant 9,724,362 - Miller , et al. August 8, 2
2017-08-08
Nanoparticle Formulations Of Low-water Solubility Actives
App 20170209375 - Miller; Warren Kenyon ;   et al.
2017-07-27
N-(4-phenyl)-n'-(3-fluorophenyl)urea Docusate
App 20170197980 - Dias; Lloyd S. ;   et al.
2017-07-13
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
Grant 9,545,384 - Miller January 17, 2
2017-01-17
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
Grant 9,233,078 - Bloom , et al. January 12, 2
2016-01-12
Solid compositions of low-solubility drugs and poloxamers
Grant 8,974,823 - Smithey , et al. March 10, 2
2015-03-10
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
Grant 8,974,827 - Bloom , et al. March 10, 2
2015-03-10
Pharmaceutical compositions with enhanced performance
Grant 8,940,800 - Babcock , et al. January 27, 2
2015-01-27
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
Grant 8,703,204 - Bloom , et al. April 22, 2
2014-04-22
Pharmaceutical compositions with enhanced performance
Grant 8,617,604 - Babcock , et al. December 31, 2
2013-12-31
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
Grant 8,309,129 - Miller , et al. November 13, 2
2012-11-13
Pharmaceutical Compositions With Enhanced Performance
App 20120264833 - Babcock; Walter C. ;   et al.
2012-10-18
Pharmaceutical compositions with enhanced performance
Grant 8,207,232 - Babcock , et al. June 26, 2
2012-06-26
Nanoparticles Comprising A Non-ionizable Cellulosic Polymer And An Amphiphilic Non-ionizable Block Copolymer
App 20100323014 - Bloom; Corey Jay ;   et al.
2010-12-23
Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material
App 20100310663 - Miller; Warren Kenyon ;   et al.
2010-12-09
Nanoparticles Comprising A Non-ionizable Polymer And An Amine-functionalized Methacrylate Copolymer
App 20100297237 - Bloom; Corey J. ;   et al.
2010-11-25
Nanoparticles Comprising A Non-ionizable Polymer And An Anionic Cellulosic Polymer
App 20100266692 - Bloom; Corey Jay ;   et al.
2010-10-21
Nanoparticles Comprising Ionizable, Poorly Water Soluble Cellulosic Polymers
App 20100215747 - Bloom; Corey Jay ;   et al.
2010-08-26
Nanoparticles Comprising Drug, A Non-ionizable Cellulosic Polymer And Tocopheryl Polyethylene Glocol Succinate
App 20100183731 - Miller; Warren Kenyon
2010-07-22
Nanoparticles Comprising A Cholesteryl Ester Transfer Protein Inhibitor And Anon-ionizable Polymer
App 20100129447 - Bloom; Corey Jay ;   et al.
2010-05-27
Nanoparticles Comprising A Drug,ethycellulose,and A Bile Salt
App 20100119603 - Miller; warren Kenyon ;   et al.
2010-05-13
Pharmaceutical Compositions With Enhanced Performance
App 20080262107 - Babcock; Walter C. ;   et al.
2008-10-23
Pharmaceutical Compositions with Enhanced Performance
App 20080064763 - Babcock; Walter Christian ;   et al.
2008-03-13
Stabilized pharmaceutical solid compositions of low-solubility drugs and poloxamers, and stabilizing polymers
App 20070148232 - Crew; Marshall David ;   et al.
2007-06-28
Solid compositions of low-solubility drugs and poloxamers
App 20070141143 - Smithey; Daniel Tod ;   et al.
2007-06-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed